Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of Osteosarcoma

NCT06714383 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Osteosarcoma

Interventions

DRUG: Trilaciclib
DRUG: Pirarubicin
DRUG: Lobaplatin

Sponsor

Peking University People's Hospital